1The research and development strategy of tibetan new drugs from the perspective of knowledge value chainCHEN Wei-wu, SUN Li-hua2049-20552The secondary development strategy of Tibetan medicine based on clinical value: taking Qingpeng ointment as an exampleCHEN Wei-wu, SUN Li-hua2056-20623Research and development of anti-leukemia drugs in China from perspective of patent informationSUN Hui, DONG Li2063-20684Analysis of the patents of belinostatZHOU Fu-ke, GUO Xiao-yun, CHI Li-na, YUAN Yue, WANG Qin-geng2069-20755Proficiency-testing of determination for benzyl hydroxybenzoate contentsYANG Rui, XU Kai, WANG Jue, ZHANG Zhao-yang, WANG Lu-lu, ZHAO Xin, LI Hai-liang, SUN Hui-min2076-20806Effects of ginseng aconite and its effective components combination on the mRNA's expression of oxidase CYP2J3 hydroxylase, CYP4A3 and CYP4F11SUN Jia, ZHANG Guang-ping, SU Ping, MA Meng, CHEN Teng-fei, YANG Yi-fei, HOU Hong-ping, ZHANG Zhong-xiu, GAO Yun-hang, SONG Ling, LI Han, YE Zu-guang2081-20887Advances in using lipocalin-type prostaglandin D synthase as delivery carrier for poorly water-soluble drugsFAN Lei, TIAN Xia, ZHANG Sheng-nan, MA Shu-li, FAN Yun-zhou2089-20948Research progress of immune checkpoint inhibitor related myocarditisXU Wei-xian, LI Hai-yan2095-20999Nonclinical efficacy of multiple sclerosis modify drugsSHAN Xiao-lei, WANG Qing-li, HUANG Fang-hua2100-210510Interpretation of Guidance on CMC Study of Investigational New Chemical Drug Applications for Phase m Clinical Trial2106-211211Enhancing the system of expedited reporting of safety data during clinical trials of drugs and strengthening the management of clinical trial risk monitoringPEI Xiao-jing, HAN Ling, WANG Tao2113-211612General considerations on first-in-human dose estimation for anti-cancer drug clinical trialsYE Xuan, ZHANG Min, YAN Li-ping, YU Bing, ZHU Fei-peng, LIU Yi-bo, WANG Qing-li, WANG Hai-xue2117-211913Establishment of a LC/MS/MS method to determine content of catecholamines in human plasmaLI Tai-feng, LIU Xue-mei, HU Lei, LUO Xing-xian, LIU Si-lu, FENG Yu-fei2120-212514A multicenter, randomized, controlled clinical trial for application of Naoxueshu oral liquid in the treatment of cerebral edema after strokeGUO Zhen-yu, ZHANG Yi, DAI Yong-qing, WU Zong-tao, HAO Dong-ning, GAO Jian-zhong, ZHENG Hu-lin, LIU Chong-xiao, ZHOU Ren, PU Jing-nan, BAI Lu-ning, JIA Yao-hui, ZHOU Xiao-feng, SHI Wei2126-212915Preliminary efficacy of butylphthalide combined with dual antiplatelet drugs in patients with perforating artery cerebral infarctionZHENG Li, LI Hong, CHEN Na, WANG Cong-jie, SONG Qiao, LIU Shan, KANG Mei, LI Jing, SONG Hai-xia, LU Hai-li2130-213416Evaluating effects of Radix Isatidis extraction on cell proliferationWU Yan-lin, ZHANG Yuan, LIU Jun, LUO Jian, GAO Hua2135-214017Analyzing dose-effect relation of Danshen-Sanqi herb pair for promoting blood circulation and removing blood stasis effects by PCA and multi-attribute comprehensive index methodsTAO Hui-juan, YUE Shi-jun, TANG Yu-ping, SHI Xu-qin, ZHOU Gui-sheng, TAN Ya-jie, ZHANG Jing, CHEN Jia-qian, PU Zong-jin, ZHAO Ming, DUAN Jin-ao2141-214718Possible anticancer mechanism of oridonin determined by reverse molecular docking and network pharmacological technologyLIU Wei, ZHANG Yan-zhong, BAI Su-ping2148-215619Preclinical pharmacokinetic study of tadalafil oral fast dissolving filmsCHEN Xiao-yun, QIN Yan, XIAO Feng, MEI Qi-bing, FAN Xin-hua2157-216220Centralized monitoring of clinical safety of Yunnan Baiyao capsules in Shanxi and Ningxia regionDENG Yue, ZHANG Liao-liao, LI Bo, YANG Da-zhao, LIU Ming-hui, WU Jie, ZHANG Cun, WANG Jian-she, ZHANG Xin-yan, LEI Gao-min, SUN Kai, HAO Chun-ju, LI Xiao-chun2163-2169 